Literature DB >> 17904528

Vascular endothelial growth factor (VEGF) suppresses ovarian granulosa cell apoptosis in vitro.

Naomichi Kosaka1, Natsuko Sudo, Akio Miyamoto, Takashi Shimizu.   

Abstract

Vascular endothelial growth factor (VEGF) inhibits the follicular atresia that resulted from granulosa cell apoptosis in the mammalian ovary. In the present study, we examined the effect of VEGF on granulosa cell apoptosis. Here, we report that VEGF suppresses granulosa cell apoptosis by inhibiting the release of caspase-activated DNase (CAD) without being associated with the mitochondrial pathway. VEGF did not stimulate or inhibit Bcl-xL and Bax, respectively, in granulosa cells. In addition, VEGF did not suppress the expression of active caspase-3, whereas follicle-stimulating hormone (FSH) inhibited caspase-3. However, VEGF and FSH suppressed the release of CAD resulting from the disintegration of the CAD-ICAD complex. These results demonstrate that VEGF is a strong survival factor for granulosa cell apoptosis (ovarian follicular atresia).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904528     DOI: 10.1016/j.bbrc.2007.09.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Upregulation of miR-33 Exacerbates Heat-Stress-Induced Apoptosis in Granulosa Cell and Follicular Atresia of Nile Tilapia (Oreochromis niloticus) by Targeting TGFβ1I1.

Authors:  Jun Qiang; Fan-Yi Tao; Qi-Si Lu; Jie He; Pao Xu
Journal:  Genes (Basel)       Date:  2022-06-02       Impact factor: 4.141

2.  The genomic response of human granulosa cells (KGN) to melatonin and specific agonists/antagonists to the melatonin receptors.

Authors:  Asma Arjoune; Marc-André Sirard
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

3.  The differential pathways of bone morphogenetic protein (BMP)-4 and -7 in the suppression of the bovine granulosa cell apoptosis.

Authors:  Takefumi Kayamori; Naomichi Kosaka; Akio Miyamoto; Takashi Shimizu
Journal:  Mol Cell Biochem       Date:  2008-12-16       Impact factor: 3.396

4.  Anti-VEGFA Therapy Reduces Tumor Growth and Extends Survival in a Murine Model of Ovarian Granulosa Cell Tumor.

Authors:  Mayra Tsoi; Marie-Noëlle Laguë; Alexandre Boyer; Marilène Paquet; Marie-Ève Nadeau; Derek Boerboom
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

5.  Luteal activity of pregnant rats with hypo-and hyperthyroidism.

Authors:  Juneo Freitas Silva; Natália Melo Ocarino; Rogéria Serakides
Journal:  J Ovarian Res       Date:  2014-07-12       Impact factor: 4.234

6.  miR-22 inhibits mouse ovarian granulosa cell apoptosis by targeting SIRT1.

Authors:  Fang Xiong; Lingqing Hu; Yun Zhang; Xiao Xiao; Juxia Xiao
Journal:  Biol Open       Date:  2016-02-24       Impact factor: 2.422

7.  Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats.

Authors:  Li Ling; Xiushan Feng; Tianqin Wei; Yan Wang; Yaping Wang; Wenqian Zhang; Lianli He; Ziling Wang; Qianru Zeng; Zhengai Xiong
Journal:  Stem Cell Res Ther       Date:  2017-12-19       Impact factor: 6.832

8.  Human umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism.

Authors:  Jia Li; QiuXian Mao; JingJun He; HaoQing She; Zhi Zhang; ChunYan Yin
Journal:  Stem Cell Res Ther       Date:  2017-03-09       Impact factor: 6.832

9.  The Increased Expression of Connexin and VEGF in Mouse Ovarian Tissue Vitrification by Follicle Stimulating Hormone.

Authors:  Yanzhou Yang; Jie Chen; Hao Wu; Xiuying Pei; Qing Chang; Wenzhi Ma; Huiming Ma; Changchun Hei; Xiaomin Zheng; Yufang Cai; Chengjun Zhao; Jia Yu; Yanrong Wang
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

Review 10.  Molecular and cellular mechanisms for the regulation of ovarian follicular function in cows.

Authors:  Takashi Shimizu
Journal:  J Reprod Dev       Date:  2016-04-21       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.